DNA is a genetic material, consisting of a long stretch of nucleotide sequences with 2 m length. It carries genetic information from one generation to another. A complete list of DNA sequence is known as a genome, which includes coding and non-coding regions of DNA. Gene is defined as a segment of DNA that codes for mRNA, and protein synthesis from the mRNA sequence. The total human genome consists of about 3.1 billion base pairs with 20,000 protein coding genes. The average length of a single gene is nearly 3000 base pairs size, and it may go up to 2.4 million.

Question

Want to see the full answer?

Answer 1

Question

Chapter 4, Problem 5WWTS

Summary Introduction

Introduction:

DNA is a genetic material, consisting of a long stretch of nucleotide sequences with 2 m length. It carries genetic information from one generation to another. A complete list of DNA sequence is known as a genome, which includes coding and non-coding regions of DNA. Gene is defined as a segment of DNA that codes for mRNA, and protein synthesis from the mRNA sequence. The total human genome consists of about 3.1 billion base pairs with 20,000 protein coding genes. The average length of a single gene is nearly 3000 base pairs size, and it may go up to 2.4 million.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Outline a method for using apomixis to maintain feminized CannabisAssume apomixis is controlled by a single dominant gene. You can choose the type of apomixis: obligate or facultative, gametophytic or sporophytic. Discuss advantages and disadvantages of your proposed method.

Kinetics: One-Compartment First-Order Absorption 1. In vivo testing provides valuable insight into a drug’s kinetics. Assessing drug kinetics following multiple routes of administration provides greater insight than a single route of administration alone. The following data was collected in 250-g rats following bolus IV, oral (PO), and intraperitoneal (ip) administration. Using this data and set of graphs, determine:(calculate for each variable) (a) k, C0, V, and AUC* for the bolus iv data (b) k, ka, B1, and AUC* for the po data c) k, ka, B1, and AUC* for the ip data (d) relative bioavailability for po vs ip, Fpo/Fip (e)absolute ip bioavailability, Fip (f) absolute po bioavailability, Fpo

3. A promising new drug is being evaluated in human trials. Based on preliminary human tests, this drug is most effective when plasma levels exceed 30 mg/L. Measurements from preliminary tests indicate the following human pharmacokinetic parameter values: t1/2,elim = 4.6hr, t1/2,abs = 0.34hr, VD = 0.29 L/kg, Foral = 72%. Based on these parameters, estimate the following if a 49 kg woman were to receive a 1000mg oral dose of this drug: (a) Estimate the plasma concentration of the drug at 1hr, 6 hr, and 20hr after taking the drug ( Concentration estimate) (b) Estimate the time for maximum plasma concentration (tmax). (c) Estimate the maximum plasma concentration (Cmax). (d) Estimate the time at which the plasma level first rises above 30 mg/L. (Note this is a trial and error problem where you must guess a time, plug it into the concentration equation, and determine if it is close to 30 mg/L. Hint: based on part (a) it should be apparent that the answer is less than 1hr.) (e)…